A PYMNTS Company

Antitrust Enforcement in the Pharmaceuticals and Medical Products Industry in China

BY | March 10, 2020

B The pharmaceutical and medical products industry in China has seen high levels of antitrust enforcement activity from 2015 onwards. This article takes stock of the cases to date, and…

B

The pharmaceutical and medical products industry in China has seen high levels of antitrust enforcement activity from 2015 onwards. This article takes stock of the cases to date, and highlights the most common antitrust issues. Notably, abuse of dominance cases involving excessive pricing and refusal to supply emerge as the most common infringements, and the market for the supply of active pharmaceutical ingredients appears to be the most actively scrutinized market. Antitrust enforcement is e

...
THIS ARTICLE IS NOT AVAILABLE FOR IP ADDRESS 44.200.194.255

Please verify email or join us to access premium content!